ThomasAlbertGrugleMD

Psychiatry • Dallas, TX

Psychiatry, Psychotherapy and Teaching

Join to view full profile

Dr. Grugle is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Grugle's full profile

Already have an account?

Office
12830 Hillcrest Rd
Ste D222
Dallas, TX 75230
Phone+1 469-250-1340

Fax+1 844-710-6013

Education & Training

Timberlawn Mental Health SystemResidency, Psychiatry, 1989 - 1993
Naval Medical Center (San Diego)Internship, Internal Medicine, 1984 - 1985
University of Texas Southwestern Medical SchoolClass of 1984
The University of Texas at DallasB.S., Biology, Magna cum Laude, 1980

Certifications & Licensure

TX State Medical License 1985 - 2025
American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification drchrono EHR, drchrono, Inc., 2011
Arthur M. Griffin Award for Outstanding Contribution to Medical Student Education UT Southwestern Medical School, Dept. of Psychiatry, 2006
Honorable Discharge United States Navy, 1988
Letter of Commendation Captain R. B. Gutshall, MSC, USN, Commanding Officer, Naval Hospital Corpus Christi, 1988
Certificate of Commendation Colonel Jerry F. Wade, USA, Commander, Corpus Christi Army Depot, 1987
Letter of Appreciation Major Jenice N. Longfield, MC, USA, Chief, PVNTMED Service, Corpus Christi Army Depot, 1987
Join now to see all

Clinical Trials

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features Start of enrollment: 2008 Mar 01
Terminated
Phase 3
Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia Start of enrollment: 2008 Mar 01
Completed
Phase 3
Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia Start of enrollment: 2008 Dec 01
Completed
Phase 3
Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia. Start of enrollment: 2008 Oct 01
Completed
Phase 3
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia Start of enrollment: 2009 May 01
Completed
Phase 3
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression Start of enrollment: 2009 Apr 01
Completed
Phase 3
A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents Start of enrollment: 2010 Jun 01
Completed
Phase 3
A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder Start of enrollment: 2010 Aug 01
Completed
Phase 3
Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression Start of enrollment: 2010 Nov 01
Completed
Phase 3
Opioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL) Start of enrollment: 2010 Dec 01
Completed
Phase 3
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia Start of enrollment: 2011 Jul 01
Completed
Phase 3
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia Start of enrollment: 2011 Sep 01
Completed
Phase 3
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder Start of enrollment: 2011 May 31
Completed
Phase 2
PEARL Schizophrenia Maintenance Start of enrollment: 2011 Sep 01
Completed
Phase 3
SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study Start of enrollment: 2012 Feb 27
Terminated
Phase 3
Join now to see all

Publications & Presentations

Authored Content

When Patients Consult Google Take Your Cues From Dr. GrugleJuly 2019

External Links

CyberCouchhttp://cybercouch.com